PLXP Insider Trading Activity and SEC Form 4 Filings
PLXP insider trading summary
No open-market insider purchases or sales of PLx Pharma Inc. (PLXP) have been reported on SEC Form 4 in the past 12 months.
Latest PLXP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 15, 2022 | Natasha Giordano | Chief Executive Officer | Buy | $15K (4,100 @ $3.65) |
| Mar 15, 2022 | Rita M O'Connor | Chief Financial Officer | Buy | $37K (10,000 @ $3.66) |
| Mar 15, 2022 | Rita M O'Connor | Chief Financial Officer | Buy | $14K (3,700 @ $3.65) |
| Jun 14, 2021 | Michael J Valentino | Executive Chairman | Buy | $7K (600 @ $12.47) |
| Jun 14, 2021 | Michael J Valentino | Executive Chairman | Buy | $64K (5,080 @ $12.50) |
| Jun 14, 2021 | Michael J Valentino | Executive Chairman | Buy | $2K (120 @ $12.51) |
| Jun 14, 2021 | Michael J Valentino | Executive Chairman | Buy | $1K (100 @ $12.48) |
| Jun 14, 2021 | Michael J Valentino | Executive Chairman | Buy | $5K (400 @ $12.45) |
| Jun 14, 2021 | Michael J Valentino | Executive Chairman | Buy | $15K (1,200 @ $12.44) |
| Jun 14, 2021 | Michael J Valentino | Executive Chairman | Buy | $4K (300 @ $12.47) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.